Ali Faraz
SEC CIK 1667937 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | CEO, Dir | 539.8K | — | $143.6K | 15 | 2023-02-15 | 2026-09-10 |
Most active insiders at TNYA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COLUMN GROUP III-A, LP | 10% | — | $3.54M |
| 2 | TCG Opportunity III GP, LLC | 10% | — | $2.37M |
| 3 | Ali Faraz | CEO, Dir | — | $32.1K |
| 4 | Tingley Whittemore | Chief Medical Off | — | $14.9K |
| 5 | Higa Tomohiro | SVP, Fin | — | $5,216 |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-11 20:10 | 2026-09-10 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | A - Grant | $0.00 | +122.0K | 539.8K | +29% | $0 |
| M | 2026-08-17 20:50 | 2026-08-17 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $0.7097 | -22.2K | 417.8K | -5% | -$15.8K |
| 2026-05-19 19:09 | 2026-05-18 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $0.7934 | -3,390 | 440.0K | -0.8% | -$2,690 | |
| M | 2026-02-17 | 2026-02-17 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $0.64 | -14.9K | 448.4K | -3% | -$9,512 |
| D | 2026-02-05 | 2026-02-03 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | A - Grant | $0.00 | +158.6K | 458.3K | +53% | $0 |
| 2025-11-17 | 2025-11-17 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $1.33 | -3,126 | 299.7K | -1% | -$4,158 | |
| M | 2025-08-18 | 2025-08-18 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $1.25 | -14.5K | 302.8K | -5% | -$18.2K |
| 2025-05-16 | 2025-05-16 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $0.44 | -3,189 | 317.3K | -1.0% | -$1,403 | |
| M | 2025-03-10 | 2025-03-10 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $0.54 | -9,741 | 324.5K | -3% | -$5,260 |
| DM | 2025-02-07 | 2025-02-06 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | A - Grant | $0.00 | +141.9K | 330.3K | +75% | $0 |
| M | 2024-08-16 | 2024-08-16 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $2.89 | -9,748 | 188.3K | -5% | -$28.2K |
| D | 2024-02-27 | 2024-02-23 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | A - Grant | $0.00 | +85.0K | 198.1K | +75% | $0 |
| 2024-02-16 | 2024-02-16 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $5.86 | -6,358 | 113.1K | -5% | -$37.3K | |
| 2023-08-18 | 2023-08-16 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | S - Sale | $3.81 | -5,563 | 119.4K | -4% | -$21.2K | |
| D | 2023-02-17 | 2023-02-15 | TNYA | Tenaya Therapeutics, Inc. | Ali Faraz | CEO, Dir | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations